Support Provided ByLearn More

Stabilizing Vaccines with Silk

New technology may bypass the need to keep vaccines cold by stabilizing them with silk.
Publish Date: Topic: Body + BrainBody & BrainNova
By Ari Daniel

At the moment, vaccines must be kept cold up until the moment that they are administered to a patient. This poses a problem in the developing world where infrastructure can interrupt the refrigeration during storage and transport. Numerous labs and companies are working to solve the problem. For instance, one Cambridge-based startup called Vaxess is using an extract from silk to stabilize vaccines, and their preliminary results are promising.

Support Provided ByLearn More

Explore More

Additional funding for this program is provided by Millicent Bell, through the Millicent and Eugene Bell Foundation.

National corporate funding for NOVA is provided by Draper. Major funding for NOVA is provided by the David H. Koch Fund for Science, the Corporation for Public Broadcasting, and PBS viewers. Additional funding is provided by the NOVA Science Trust.